Cargando…

Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project

The diagnostic criteria for CLL rely on morphology and immunophenotype. Current approaches have limitations affecting reproducibility and there is no consensus on the role of new markers. The aim of this project was to identify reproducible criteria and consensus on markers recommended for the diagn...

Descripción completa

Detalles Bibliográficos
Autores principales: Rawstron, Andy C., Kreuzer, Karl‐Anton, Soosapilla, Asha, Spacek, Martin, Stehlikova, Olga, Gambell, Peter, McIver‐Brown, Neil, Villamor, Neus, Psarra, Katherina, Arroz, Maria, Milani, Raffaella, de la Serna, Javier, Cedena, M. Teresa, Jaksic, Ozren, Nomdedeu, Josep, Moreno, Carol, Rigolin, Gian Matteo, Cuneo, Antonio, Johansen, Preben, Johnsen, Hans E., Rosenquist, Richard, Niemann, Carsten Utoft, Kern, Wolfgang, Westerman, David, Trneny, Marek, Mulligan, Stephen, Doubek, Michael, Pospisilova, Sarka, Hillmen, Peter, Oscier, David, Hallek, Michael, Ghia, Paolo, Montserrat, Emili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817234/
https://www.ncbi.nlm.nih.gov/pubmed/29024461
http://dx.doi.org/10.1002/cyto.b.21595
_version_ 1783300834392539136
author Rawstron, Andy C.
Kreuzer, Karl‐Anton
Soosapilla, Asha
Spacek, Martin
Stehlikova, Olga
Gambell, Peter
McIver‐Brown, Neil
Villamor, Neus
Psarra, Katherina
Arroz, Maria
Milani, Raffaella
de la Serna, Javier
Cedena, M. Teresa
Jaksic, Ozren
Nomdedeu, Josep
Moreno, Carol
Rigolin, Gian Matteo
Cuneo, Antonio
Johansen, Preben
Johnsen, Hans E.
Rosenquist, Richard
Niemann, Carsten Utoft
Kern, Wolfgang
Westerman, David
Trneny, Marek
Mulligan, Stephen
Doubek, Michael
Pospisilova, Sarka
Hillmen, Peter
Oscier, David
Hallek, Michael
Ghia, Paolo
Montserrat, Emili
author_facet Rawstron, Andy C.
Kreuzer, Karl‐Anton
Soosapilla, Asha
Spacek, Martin
Stehlikova, Olga
Gambell, Peter
McIver‐Brown, Neil
Villamor, Neus
Psarra, Katherina
Arroz, Maria
Milani, Raffaella
de la Serna, Javier
Cedena, M. Teresa
Jaksic, Ozren
Nomdedeu, Josep
Moreno, Carol
Rigolin, Gian Matteo
Cuneo, Antonio
Johansen, Preben
Johnsen, Hans E.
Rosenquist, Richard
Niemann, Carsten Utoft
Kern, Wolfgang
Westerman, David
Trneny, Marek
Mulligan, Stephen
Doubek, Michael
Pospisilova, Sarka
Hillmen, Peter
Oscier, David
Hallek, Michael
Ghia, Paolo
Montserrat, Emili
author_sort Rawstron, Andy C.
collection PubMed
description The diagnostic criteria for CLL rely on morphology and immunophenotype. Current approaches have limitations affecting reproducibility and there is no consensus on the role of new markers. The aim of this project was to identify reproducible criteria and consensus on markers recommended for the diagnosis of CLL. ERIC/ESCCA members classified 14 of 35 potential markers as “required” or “recommended” for CLL diagnosis, consensus being defined as >75% and >50% agreement, respectively. An approach to validate “required” markers using normal peripheral blood was developed. Responses were received from 150 participants with a diagnostic workload >20 CLL cases per week in 23/150 (15%), 5–20 in 82/150 (55%), and <5 cases per week in 45/150 (30%). The consensus for “required” diagnostic markers included: CD19, CD5, CD20, CD23, Kappa, and Lambda. “Recommended” markers potentially useful for differential diagnosis were: CD43, CD79b, CD81, CD200, CD10, and ROR1. Reproducible criteria for component reagents were assessed retrospectively in 14,643 cases from 13 different centers and showed >97% concordance with current approaches. A pilot study to validate staining quality was completed in 11 centers. Markers considered as “required” for the diagnosis of CLL by the participants in this study (CD19, CD5, CD20, CD23, Kappa, and Lambda) are consistent with current diagnostic criteria and practice. Importantly, a reproducible approach to validate and apply these markers in individual laboratories has been identified. Finally, a consensus “recommended” panel of markers to refine diagnosis in borderline cases (CD43, CD79b, CD81, CD200, CD10, and ROR1) has been defined and will be prospectively evaluated. © 2017 International Clinical Cytometry Society
format Online
Article
Text
id pubmed-5817234
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-58172342018-02-26 Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project Rawstron, Andy C. Kreuzer, Karl‐Anton Soosapilla, Asha Spacek, Martin Stehlikova, Olga Gambell, Peter McIver‐Brown, Neil Villamor, Neus Psarra, Katherina Arroz, Maria Milani, Raffaella de la Serna, Javier Cedena, M. Teresa Jaksic, Ozren Nomdedeu, Josep Moreno, Carol Rigolin, Gian Matteo Cuneo, Antonio Johansen, Preben Johnsen, Hans E. Rosenquist, Richard Niemann, Carsten Utoft Kern, Wolfgang Westerman, David Trneny, Marek Mulligan, Stephen Doubek, Michael Pospisilova, Sarka Hillmen, Peter Oscier, David Hallek, Michael Ghia, Paolo Montserrat, Emili Cytometry B Clin Cytom Original Articles The diagnostic criteria for CLL rely on morphology and immunophenotype. Current approaches have limitations affecting reproducibility and there is no consensus on the role of new markers. The aim of this project was to identify reproducible criteria and consensus on markers recommended for the diagnosis of CLL. ERIC/ESCCA members classified 14 of 35 potential markers as “required” or “recommended” for CLL diagnosis, consensus being defined as >75% and >50% agreement, respectively. An approach to validate “required” markers using normal peripheral blood was developed. Responses were received from 150 participants with a diagnostic workload >20 CLL cases per week in 23/150 (15%), 5–20 in 82/150 (55%), and <5 cases per week in 45/150 (30%). The consensus for “required” diagnostic markers included: CD19, CD5, CD20, CD23, Kappa, and Lambda. “Recommended” markers potentially useful for differential diagnosis were: CD43, CD79b, CD81, CD200, CD10, and ROR1. Reproducible criteria for component reagents were assessed retrospectively in 14,643 cases from 13 different centers and showed >97% concordance with current approaches. A pilot study to validate staining quality was completed in 11 centers. Markers considered as “required” for the diagnosis of CLL by the participants in this study (CD19, CD5, CD20, CD23, Kappa, and Lambda) are consistent with current diagnostic criteria and practice. Importantly, a reproducible approach to validate and apply these markers in individual laboratories has been identified. Finally, a consensus “recommended” panel of markers to refine diagnosis in borderline cases (CD43, CD79b, CD81, CD200, CD10, and ROR1) has been defined and will be prospectively evaluated. © 2017 International Clinical Cytometry Society John Wiley and Sons Inc. 2018-01-17 2018-01 /pmc/articles/PMC5817234/ /pubmed/29024461 http://dx.doi.org/10.1002/cyto.b.21595 Text en © 2017 The Authors. Cytometry Part B: Clinical Cytometry published by Wiley Periodicals, Inc. on behalf of International Clinical Cytometry Society This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Rawstron, Andy C.
Kreuzer, Karl‐Anton
Soosapilla, Asha
Spacek, Martin
Stehlikova, Olga
Gambell, Peter
McIver‐Brown, Neil
Villamor, Neus
Psarra, Katherina
Arroz, Maria
Milani, Raffaella
de la Serna, Javier
Cedena, M. Teresa
Jaksic, Ozren
Nomdedeu, Josep
Moreno, Carol
Rigolin, Gian Matteo
Cuneo, Antonio
Johansen, Preben
Johnsen, Hans E.
Rosenquist, Richard
Niemann, Carsten Utoft
Kern, Wolfgang
Westerman, David
Trneny, Marek
Mulligan, Stephen
Doubek, Michael
Pospisilova, Sarka
Hillmen, Peter
Oscier, David
Hallek, Michael
Ghia, Paolo
Montserrat, Emili
Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project
title Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project
title_full Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project
title_fullStr Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project
title_full_unstemmed Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project
title_short Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project
title_sort reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: an european research initiative on cll (eric) & european society for clinical cell analysis (escca) harmonisation project
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817234/
https://www.ncbi.nlm.nih.gov/pubmed/29024461
http://dx.doi.org/10.1002/cyto.b.21595
work_keys_str_mv AT rawstronandyc reproduciblediagnosisofchroniclymphocyticleukemiabyflowcytometryaneuropeanresearchinitiativeoncllericeuropeansocietyforclinicalcellanalysisesccaharmonisationproject
AT kreuzerkarlanton reproduciblediagnosisofchroniclymphocyticleukemiabyflowcytometryaneuropeanresearchinitiativeoncllericeuropeansocietyforclinicalcellanalysisesccaharmonisationproject
AT soosapillaasha reproduciblediagnosisofchroniclymphocyticleukemiabyflowcytometryaneuropeanresearchinitiativeoncllericeuropeansocietyforclinicalcellanalysisesccaharmonisationproject
AT spacekmartin reproduciblediagnosisofchroniclymphocyticleukemiabyflowcytometryaneuropeanresearchinitiativeoncllericeuropeansocietyforclinicalcellanalysisesccaharmonisationproject
AT stehlikovaolga reproduciblediagnosisofchroniclymphocyticleukemiabyflowcytometryaneuropeanresearchinitiativeoncllericeuropeansocietyforclinicalcellanalysisesccaharmonisationproject
AT gambellpeter reproduciblediagnosisofchroniclymphocyticleukemiabyflowcytometryaneuropeanresearchinitiativeoncllericeuropeansocietyforclinicalcellanalysisesccaharmonisationproject
AT mciverbrownneil reproduciblediagnosisofchroniclymphocyticleukemiabyflowcytometryaneuropeanresearchinitiativeoncllericeuropeansocietyforclinicalcellanalysisesccaharmonisationproject
AT villamorneus reproduciblediagnosisofchroniclymphocyticleukemiabyflowcytometryaneuropeanresearchinitiativeoncllericeuropeansocietyforclinicalcellanalysisesccaharmonisationproject
AT psarrakatherina reproduciblediagnosisofchroniclymphocyticleukemiabyflowcytometryaneuropeanresearchinitiativeoncllericeuropeansocietyforclinicalcellanalysisesccaharmonisationproject
AT arrozmaria reproduciblediagnosisofchroniclymphocyticleukemiabyflowcytometryaneuropeanresearchinitiativeoncllericeuropeansocietyforclinicalcellanalysisesccaharmonisationproject
AT milaniraffaella reproduciblediagnosisofchroniclymphocyticleukemiabyflowcytometryaneuropeanresearchinitiativeoncllericeuropeansocietyforclinicalcellanalysisesccaharmonisationproject
AT delasernajavier reproduciblediagnosisofchroniclymphocyticleukemiabyflowcytometryaneuropeanresearchinitiativeoncllericeuropeansocietyforclinicalcellanalysisesccaharmonisationproject
AT cedenamteresa reproduciblediagnosisofchroniclymphocyticleukemiabyflowcytometryaneuropeanresearchinitiativeoncllericeuropeansocietyforclinicalcellanalysisesccaharmonisationproject
AT jaksicozren reproduciblediagnosisofchroniclymphocyticleukemiabyflowcytometryaneuropeanresearchinitiativeoncllericeuropeansocietyforclinicalcellanalysisesccaharmonisationproject
AT nomdedeujosep reproduciblediagnosisofchroniclymphocyticleukemiabyflowcytometryaneuropeanresearchinitiativeoncllericeuropeansocietyforclinicalcellanalysisesccaharmonisationproject
AT morenocarol reproduciblediagnosisofchroniclymphocyticleukemiabyflowcytometryaneuropeanresearchinitiativeoncllericeuropeansocietyforclinicalcellanalysisesccaharmonisationproject
AT rigolingianmatteo reproduciblediagnosisofchroniclymphocyticleukemiabyflowcytometryaneuropeanresearchinitiativeoncllericeuropeansocietyforclinicalcellanalysisesccaharmonisationproject
AT cuneoantonio reproduciblediagnosisofchroniclymphocyticleukemiabyflowcytometryaneuropeanresearchinitiativeoncllericeuropeansocietyforclinicalcellanalysisesccaharmonisationproject
AT johansenpreben reproduciblediagnosisofchroniclymphocyticleukemiabyflowcytometryaneuropeanresearchinitiativeoncllericeuropeansocietyforclinicalcellanalysisesccaharmonisationproject
AT johnsenhanse reproduciblediagnosisofchroniclymphocyticleukemiabyflowcytometryaneuropeanresearchinitiativeoncllericeuropeansocietyforclinicalcellanalysisesccaharmonisationproject
AT rosenquistrichard reproduciblediagnosisofchroniclymphocyticleukemiabyflowcytometryaneuropeanresearchinitiativeoncllericeuropeansocietyforclinicalcellanalysisesccaharmonisationproject
AT niemanncarstenutoft reproduciblediagnosisofchroniclymphocyticleukemiabyflowcytometryaneuropeanresearchinitiativeoncllericeuropeansocietyforclinicalcellanalysisesccaharmonisationproject
AT kernwolfgang reproduciblediagnosisofchroniclymphocyticleukemiabyflowcytometryaneuropeanresearchinitiativeoncllericeuropeansocietyforclinicalcellanalysisesccaharmonisationproject
AT westermandavid reproduciblediagnosisofchroniclymphocyticleukemiabyflowcytometryaneuropeanresearchinitiativeoncllericeuropeansocietyforclinicalcellanalysisesccaharmonisationproject
AT trnenymarek reproduciblediagnosisofchroniclymphocyticleukemiabyflowcytometryaneuropeanresearchinitiativeoncllericeuropeansocietyforclinicalcellanalysisesccaharmonisationproject
AT mulliganstephen reproduciblediagnosisofchroniclymphocyticleukemiabyflowcytometryaneuropeanresearchinitiativeoncllericeuropeansocietyforclinicalcellanalysisesccaharmonisationproject
AT doubekmichael reproduciblediagnosisofchroniclymphocyticleukemiabyflowcytometryaneuropeanresearchinitiativeoncllericeuropeansocietyforclinicalcellanalysisesccaharmonisationproject
AT pospisilovasarka reproduciblediagnosisofchroniclymphocyticleukemiabyflowcytometryaneuropeanresearchinitiativeoncllericeuropeansocietyforclinicalcellanalysisesccaharmonisationproject
AT hillmenpeter reproduciblediagnosisofchroniclymphocyticleukemiabyflowcytometryaneuropeanresearchinitiativeoncllericeuropeansocietyforclinicalcellanalysisesccaharmonisationproject
AT oscierdavid reproduciblediagnosisofchroniclymphocyticleukemiabyflowcytometryaneuropeanresearchinitiativeoncllericeuropeansocietyforclinicalcellanalysisesccaharmonisationproject
AT hallekmichael reproduciblediagnosisofchroniclymphocyticleukemiabyflowcytometryaneuropeanresearchinitiativeoncllericeuropeansocietyforclinicalcellanalysisesccaharmonisationproject
AT ghiapaolo reproduciblediagnosisofchroniclymphocyticleukemiabyflowcytometryaneuropeanresearchinitiativeoncllericeuropeansocietyforclinicalcellanalysisesccaharmonisationproject
AT montserratemili reproduciblediagnosisofchroniclymphocyticleukemiabyflowcytometryaneuropeanresearchinitiativeoncllericeuropeansocietyforclinicalcellanalysisesccaharmonisationproject